GI
NRIX icon

GAMMA Investing’s Nurix Therapeutics NRIX Stock Holding History

GAMMA Investing’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Buy
650
+74
+13% +$1.26K ﹤0.01% 2970
2026
Q1 		$8.93K Buy
576
+75
+15% +$1.24K ﹤0.01% 3122
2025
Q4 		$9.5K Sell
501
-210
-30% -$3.02K ﹤0.01% 3002
2025
Q3 		$6.57K Sell
711
-126
-15% -$1.31K ﹤0.01% 3067
2025
Q2 		$9.53K Sell
837
-343
-29% -$3.71K ﹤0.01% 2830
2025
Q1 		$14K Sell
1,180
-3,458
-75% -$57.8K ﹤0.01% 2582
2024
Q4 		$87.4K Sell
4,638
-63
-1% -$1.44K 0.01% 1208
2024
Q3 		$106K Buy
4,701
+135
+3% +$3.06K 0.01% 966
2024
Q2 		$95.3K Buy
4,566
+3,424
+300% +$53.3K 0.01% 805
2024
Q1 		$16.8K Buy
1,142
+703
+160% +$7.56K ﹤0.01% 1765
2023
Q4 		$3.47K Buy
+439
New +$3.01K ﹤0.01% 2387

Other funds holding NRIX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's NRIX Position: Q2 2026 in Review

GAMMA Investing increased its Nurix Therapeutics (NRIX) stake by 13% in Q2 2026, buying an estimated $1.26K and bringing the position to 650 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

GAMMA Investing first reported a position in NRIX in Q4 2023 and has held it in 11 quarters since. The position peaked at $106K in Q3 2024. 10 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • GAMMA Investing held 650 shares of Nurix Therapeutics worth $15.8K as of Q2 2026.
  • GAMMA Investing bought 74 Nurix Therapeutics shares in Q2 2026, an estimated $1.26K.
  • Nurix Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2970 holding.
  • GAMMA Investing first reported a position in Nurix Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Nurix Therapeutics position peaked at $106K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.